CGEN — Compugen Cashflow Statement
0.000.00%
- $234.49m
- $88.85m
- $72.76m
Annual cashflow statement for Compugen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -34.2 | -33.7 | -18.8 | -14.2 | 35.3 |
| Depreciation | |||||
| Non-Cash Items | 4.23 | 4.65 | 3.1 | 1.3 | 1.16 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 6.82 | -5.55 | -20.7 | 62 | -5.35 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -22.7 | -34.1 | -35.9 | 49.6 | 31.6 |
| Capital Expenditures | -0.292 | -0.487 | -0.172 | -0.118 | -0.306 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 6.91 | 37.5 | 35.7 | -46.1 | 30.3 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 6.62 | 37.1 | 35.5 | -46.3 | 30 |
| Financing Cash Flow Items | — | — | — | — | -0.004 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 16.8 | 0.353 | 3.08 | 0.554 | 10.6 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.704 | 2.91 | 2.83 | 3.97 | 72.4 |